WallStreetZenWallStreetZen

NASDAQ: SGMT
Sagimet Biosciences Inc Earnings & Revenue

SGMT earnings and revenue history

Current Revenue
$2.0M
Current Earnings
-$27.9M
Current Profit Margin
-1,395.9%

SGMT Return on Equity

Current Company
-61.9%
Current Industry
16.8%
Current Market
30.8%
SGMT's Return on Equity (-61.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SGMT announces earnings.

SGMT Return on Assets

Current Company
-26.9%
Current Industry
3.2%
SGMT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SGMT Return on Capital Employed

Current Company
-14.69%
Current Industry
-42.4%

SGMT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SGMT$2.00M-$27.78M-$27.92MN/AN/A
NVCT$0.00-$22.38M-$22.38MN/AN/A
TVGN$0.00-$49.37M-$51.21MN/AN/A
BOLDN/AN/AN/AN/AN/A
MDWD$19.85M-$7.46M-$12.75M+42.81%N/A

Sagimet Biosciences Earnings & Revenue FAQ

What were SGMT's earnings last quarter?

Sagimet Biosciences (NASDAQ: SGMT) reported Q1 2024 earnings per share (EPS) of -$0.23, up 99.35% year over year. Total Sagimet Biosciences earnings for the quarter were -$6.63 million. In the same quarter last year, Sagimet Biosciences's earnings per share (EPS) was -$35.58.

If you're new to stock investing, here's how to buy Sagimet Biosciences stock.

What was SGMT's earnings growth in the past year?

As of Q2 2024, Sagimet Biosciences's earnings has grown year over year. Sagimet Biosciences's earnings in the past year totalled -$27.92 million.

What was SGMT's revenue last quarter?

Sagimet Biosciences (NASDAQ: SGMT) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Sagimet Biosciences's revenue was $0.00.

What was SGMT's revenue growth in the past year?

As of Q2 2024, Sagimet Biosciences's revenue has grown null year over year. Sagimet Biosciences's revenue in the past year totalled $2.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.